[{"uuid": "a66a4c55-8f61-3986-9edd-c6f19c618415", "title": "Climb Bio Signs Deal With Beijing Mabworks Biotech to Develop Antibody for IgA Nephropathy", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/climb-bio-signs-deal-beijing-172707143.html", "providerPublishTime": 1736443627, "type": "STORY"}, {"uuid": "3da33509-aa2f-37ab-9c14-afd52c08d9a3", "title": "Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/climb-bio-expands-pipeline-exclusive-120000545.html", "providerPublishTime": 1736424000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HPitbdp9N5zE.42TwFDHng--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b6e600f3e302fa66aa6dc30453d5e383", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I0lqam161Bw0BO0kx1TOCg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b6e600f3e302fa66aa6dc30453d5e383", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLYM"]}, {"uuid": "8da04897-3ae4-3daf-85e5-3846c4c93acb", "title": "Climb Bio to Join Nasdaq Biotechnology Index", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/climb-bio-join-nasdaq-biotechnology-154730192.html", "providerPublishTime": 1734623250, "type": "STORY"}, {"uuid": "ee0bfe3f-4461-385f-9a18-f6624c162bae", "title": "Climb Bio to be Added to the Nasdaq Biotechnology Index", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/climb-bio-added-nasdaq-biotechnology-120000270.html", "providerPublishTime": 1734609600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HPitbdp9N5zE.42TwFDHng--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b6e600f3e302fa66aa6dc30453d5e383", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I0lqam161Bw0BO0kx1TOCg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b6e600f3e302fa66aa6dc30453d5e383", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLYM"]}, {"uuid": "ba7778e2-b417-3969-a341-117b26eddb29", "title": "Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/climb-bio-appoints-douglas-e-120000614.html", "providerPublishTime": 1731326400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HPitbdp9N5zE.42TwFDHng--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b6e600f3e302fa66aa6dc30453d5e383", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I0lqam161Bw0BO0kx1TOCg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b6e600f3e302fa66aa6dc30453d5e383", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLYM"]}, {"uuid": "721da990-6824-35a8-a934-c29f423e4b84", "title": "TEDCO's First Round of Equitech Growth Fund Awardees Unveiled", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/tedcos-first-round-equitech-growth-151600438.html", "providerPublishTime": 1733930160, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.lRz9t08fL9mDE6kSYf9Bg--~B/aD0yNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/03a566c03734ea0d5bc155eb7fd3f806", "width": 400, "height": 267, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/rk3sRbmmqJXhluS_ECRTiw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/03a566c03734ea0d5bc155eb7fd3f806", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "e7db339c-28d8-330b-a51e-7002a630b708", "title": "The Glenlivet is Taking Back Tartan This Holiday Season as it Reweaves Heritage With a Modern Twist", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/glenlivet-taking-back-tartan-holiday-140000632.html", "providerPublishTime": 1733752800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/PMVBhKV4Vzw2KciapFCllg--~B/aD0xMjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0f57c31a3ffdd251f3b317af0d654fbd", "width": 400, "height": 127, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Ry1mq36FWdPVVBLNLKnazA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0f57c31a3ffdd251f3b317af0d654fbd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PDRDF", "PRNDY"]}, {"uuid": "d7746237-86a0-3074-b988-0f556b815e79", "title": "Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/climb-bio-reports-third-quarter-210500406.html", "providerPublishTime": 1731445500, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HPitbdp9N5zE.42TwFDHng--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b6e600f3e302fa66aa6dc30453d5e383", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I0lqam161Bw0BO0kx1TOCg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b6e600f3e302fa66aa6dc30453d5e383", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLYM"]}, {"uuid": "1d914a57-299d-359e-a74f-32a9797a32fd", "title": "Climb Bio Names Douglas Williams Board Chair", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/climb-bio-names-douglas-williams-122747554.html", "providerPublishTime": 1731328067, "type": "STORY"}]